Reduction of Smoking in Cardiac Disease Patients

Completed · Phase 2

Conditions studied: Cardiovascular Disease, Tobacco Use Disorder

In brief

This study evaluates the effect of smoking reduction vs usual care (quitting advice only) for individuals with peripheral arterial disease who smoke.

Key facts

Study ID

NCT00469885

Run by

National Institute on Drug Abuse (NIDA)

People needed

152

Starts

2001-01-01

Expected to finish

2005-12-01

Last updated by the study team

2017-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be included in the study, participants must have peripheral arterial disease (defined as ankle Brachial Index equal to or less than 0.85 or history of prior revascularization) and they must be daily smokers (defined as at least 1 cigarette, cigar, or tobacco pipe daily).

Where it is running

• Univeristy of Minnesota — Minneapolis, Minnesota, United States
• Univerisity of Minnesota — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.